# Prevention of Renal and Vascular Endstage Disease Intervention Trial

> **NCT03073018** · PHASE3 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 864 (actual)

## Conditions studied

- Microalbuminuria
- Cardiovascular Diseases
- Renal Disease

## Interventions

- **DRUG:** Fosinopril
- **DRUG:** Pravastatin
- **DRUG:** Fosinopril Placebo
- **DRUG:** Pravastatin Placebo

## Key facts

- **NCT ID:** NCT03073018
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2003-06
- **Final completion:** 2003-11
- **Target enrollment:** 864 (ACTUAL)
- **Last updated:** 2017-03-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073018, "Prevention of Renal and Vascular Endstage Disease Intervention Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03073018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*